首页> 美国卫生研究院文献>Annals of Surgical Innovation and Research >Safety of carboxymethylcellulose/polyethylene oxide for the prevention of adhesions in lumbar disc herniation – consecutive case series review
【2h】

Safety of carboxymethylcellulose/polyethylene oxide for the prevention of adhesions in lumbar disc herniation – consecutive case series review

机译:羧甲基纤维素/聚环氧乙烷预防腰椎间盘突出症粘连的安全性–连续病例系列审查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundEpidural fibrosis is regarded as a cause of failed back surgery syndrome (FBSS) when excessive adhesional/fibrotic scar tissue causes compression, pain or discomfort by tethering of nerve tissue to the surrounding muscle or bone. Fibrosis inhibitors could therefore increase the success rate of spinal surgery and decrease the need for reoperations. In recent years, bio-resorbable gels or films for the prevention of peridural fibrosis and post-operative adhesions have been developed that look clinically promising. This included a 100% synthetic, sterile, absorbable gel combinations of carboxymethylcellulose (CMC) and polyethylene oxide (PEO) used to coat the dura to reduce scarring after discectomy which became available in Europe in 2002. However, given the burden of the problem and unfavorable experience with other types of adhesion-reduction agents, our unit decided to evaluate the safety of CMC/PEO in a large population of patients undergoing spinal microdiscectomy for herniation.
机译:背景技术当过多的粘连/纤维化瘢痕组织通过将神经组织束缚于周围的肌肉或骨骼而导致压迫,疼痛或不适时,硬膜上纤维化被认为是失败的背部手术综合征(FBSS)的原因。因此,纤维化抑制剂可以提高脊柱手术的成功率并减少再次手术的需要。近年来,已开发出用于预防硬膜外纤维化和术后粘连的生物可吸收凝胶或薄膜,这些在临床上看似有希望。其中包括2002年在欧洲上市的羧甲基纤维素(CMC)和聚环氧乙烷(PEO)的100%合成,无菌,可吸收凝胶组合物,用于覆盖硬脑膜以减少结疤后的瘢痕形成。但是,考虑到该问题的负担和由于在使用其他类型的减少粘连剂方面缺乏良好的经验,我们的部门决定评估CMC / PEO在接受脊柱微椎间盘切除术以进行椎间盘突出的患者中的安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号